Acrivon Therapeutics, Inc. 10-K filing
Filed 2026-03-19 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-115123
- Form type
- 10-K
- CIK
- 0001781174
- Primary document
- https://www.sec.gov/Archives/edgar/data/1781174/000119312526115123/acrv-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Acrivon Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-84.1M | - | - |
| Net Income | $-77.9M | - | - |
| Eps Basic | -2.02 | - | - |
| Eps Diluted | -2.02 | - | - |
| Cash And Equivalents | $41.5M | - | - |
| Total Assets | $129.7M | - | - |
| Total Liabilities | $17.2M | - | - |
| Shareholders Equity | $112.5M | - | - |
| Operating Cash Flow | $-63.7M | - | - |
| Capital Expenditures | $1.7M | - | - |